Survival rates and probabilities of death in patients with exocrine pancreatic cancer (EPC) were investigated in a population-based study. The study found that the overall 5-year relative survival rate at diagnosis for pancreatic ductal adenocarcinoma (PDAC) was 8.5%. Among PDAC patients who survived for 2 years, the 3-year conditional survival rate was 50.1%, and among those who survived for 5 years, the 5-year conditional survival rate was 77.6%. The study also revealed that elderly patients with localized or regional-stage PDAC who underwent surgery had comparable conditional survival rates to younger patients.
Journal Article by Kang MJ, Ha J (…) Han SS et 3 al. in Ann Surg Oncol
© 2023. Society of Surgical Oncology.